Find a Clinical Trial
Filter
A Phase 3 Study of Sotatercept for the Treatment of PAH
Pulmonary hypertension
All genders
18-18
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk PAH Patients
Pulmonary hypertension
All genders
18+
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
A Phase 3 Study of Sotatercept in Participants with PAH WHO FC III or FC IV at High Risk of Mortality
Pulmonary hypertension
All genders
18-75
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Diffuse large B-cell lymphoma
All genders
75+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
TETON-PPF
Pulmonary fibrosis
All genders
18-100
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Pulmonary fibrosis
All genders
40+
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Keros PAH Study
Pulmonary arterial hypertension (PAH)
All genders
18-100
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Pivotal Evaluation of Abdominal Neuromuscular Electrical Stimulation for Weaning from Mechanical Ventilation (PREVENT)
Medical illness
All genders
22+
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Lymphomas (adult)
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE)
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
Pulmonary fibrosis
All genders
40-99
Recruiting now
Department of Medicine, Division of Pulmonary, Critical Care + Sleep Medicine